Clozapine - Revised recommendations for routine blood count monitoring for the risk of agranulocytosis
09/09/2025
Medicines for human use
Direct healthcare professional communication (DHPC)
Important Safety Information from Viatris Healthcare Limited and Clonmel Healthcare Limited regarding clozapine: revised recommendations for routine blood count monitoring for the risk of agranulocytosis